Catheter Precision Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0.44	0.01	0.02	0.26	7.2	6.26	5.87	5.98
Revenue Growth (YoY)	3057.14%	-36.36%	-91.51%	-96.40%	15.06%	6.59%	-1.77%	-
Cost of Revenue	0.03	0.16	1.56	2.17	8.85	4.21	4.17	3.14
Gross Profit	0.41	-0.15	-1.54	-1.91	-1.65	2.05	1.71	2.84
Selling, General & Admin	17.12	16.25	15.48	24.53	51.55	30.44	14.95	5.32
Research & Development	0.48	6.39	12.25	8.96	4.53	2.78	4.52	1.72
Other Operating Expenses	60.93	4.17	0	0	0	0	0	0
Operating Expenses	78.53	26.81	27.73	33.49	56.08	33.21	19.47	7.04
Operating Income	-78.12	-26.96	-29.27	-35.4	-57.73	-31.16	-17.76	-4.2
Interest Expense / Income	0	0	0	0	0.25	0.01	0	0
Other Expense / Income	-7.55	-0.1	-4.2	0.64	-1.04	-0.35	-	-
Pretax Income	-70.57	-26.86	-25.07	-36.04	-56.94	-30.82	-17.76	-4.2
Income Tax	0	0	0	0.01	0.02	0.01	0	0
Net Income	-70.57	-26.87	-25.07	-36.05	-56.96	-30.83	-17.77	-4.2
Preferred Dividends	0.8	0	0	0	0	0	0	0
Net Income Common	-71.37	-26.87	-25.07	-36.05	-56.96	-30.83	-17.77	-4.2
Shares Outstanding (Basic)	5	1	0	0	0	0	0	0
Shares Outstanding (Diluted)	5	1	0	0	0	0	0	0
Shares Change	431.53%	923.59%	197.23%	223.00%	42.47%	22.33%	8.54%	-
EPS (Basic)	-12.99	-25.98	-248.22	-1061.00	-5414.00	-4175.00	-2937.50	-750.00
EPS (Diluted)	-12.99	-25.98	-248.22	-1061.00	-5414.00	-4175.00	-2937.50	-750.00
Free Cash Flow	-20.7	-22.55	-27.3	-28.37	-33.44	-19.09	-6.07	-2.1
Free Cash Flow Per Share	-3.77	-21.81	-270.26	-834.93	-3178.80	-2585.32	-1005.63	-376.91
Gross Margin	93.21%	-1050.00%	-6990.91%	-738.61%	-22.93%	32.78%	29.05%	47.49%
Operating Margin	-17673.98%	-192578.57%	-133027.27%	-13668.34%	-801.92%	-498.00%	-302.56%	-70.25%
Profit Margin	-16147.51%	-191892.86%	-113954.55%	-13916.99%	-791.18%	-492.76%	-302.64%	-70.31%
Free Cash Flow Margin	-4682.13%	-161050.00%	-124072.73%	-10954.05%	-464.52%	-305.10%	-103.41%	-35.07%
EBITDA	-68.5	-26.44	-23.5	-33.67	-54.94	-30.18	-17.54	-4.1
EBITDA Margin	-15497.06%	-188864.29%	-106822.73%	-13001.16%	-763.19%	-482.40%	-298.84%	-68.66%
Depreciation & Amortization	2.08	0.42	1.57	2.37	1.75	0.62	0.22	0.1
EBIT	-70.57	-26.86	-25.07	-36.04	-56.69	-30.81	-17.76	-4.2
EBIT Margin	-15966.52%	-191871.43%	-113936.36%	-13914.29%	-787.50%	-492.38%	-302.56%	-70.25%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).